Health Condition 1: I229- Subsequent ST elevation (STEMI) myocardial infarction of unspecified site
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Cardiological Society of India
Eligibility
Inclusion criteria
Inclusion criteria: All consecutive patients above the age of 18 years with STEMI or with new LBBB on 12 lead ECG and diagnosed as acute myocardial infarction (MI) as per the fourth universal definition of MI and COVID-19 positive. The cases could be STEMI patients shown to be COVID-19 positive during routine screening after admission or referred from elsewhere as COVID positive or STEMI developing in the hospital after admission for treatment of COVID 19 infection. COVID-19 infection should be confirmed with RTPCR / Truenat / CBnat / rapid antigen test. Age and sex-matched STEMI patients who are COVID negative will be enrolled as the control group for comparison in a 2:1 ratio.
Exclusion criteria
Exclusion criteria: patients below the age of 18 years Patients with STEMI who are COVID-19 negative
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To find out differences in the composite of in-hospital mortality, heart failure, shock, stroke and systemic embolizations in COVID-19 infected STEMI patients compared to age and sex-matched non-infected STEMI patients treated during the same period. 2. To find out changes in the management strategies of COVID-infected STEMI patients compared to non-infected age and sex-matched STEMI controls treated during the same period. Timepoint: This nationwide retrospective observational study on the clinical presentation, clinical course, and in-hospital outcomes of COVID-infected STEMI patients admitted during the period May 1st, 2020 to December 31 st, 2020. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. In-hospital mortality in COVID 19 infected STEMI patients 2. Incidence of stroke or systemic embolization in COVID infected STEMI patients 3. Incidence of heart failure in COVID 19 infected STEMI patients. 4. Frequency of use of mechanical ventilation COVID 19 infected STEMI cases 5. Incidence of ARDS in COVID 19 infected STEMI cases. Timepoint: This is a multicentric retrospective cross-sectional study of all consecutive COVID-19 infected STEMI patients admitted during the period May 1st, 2020 to, December 31st 2020 in selected hospitals across India. | — |
Countries
India
Contacts
Public ContactDr Jabir Abdullakutty
Director of Academic Affairs and Clinical Research
Outcome results
None listed